THCA 16.5%. THC 0.38%. CBDA 0.033%. CBD 0%. CBGA 0.30%. LABEL TOTALS THC 14.8% CBD 0.029%.
The standard terpene profile shows β- caryophyllene and limonene dominance with lower but significant levels of myrcene. The cannabinoid profile suggests it would be well tolerated by cannabis tolerant patients not highly susceptible to anxiety. Patients with depression and gastric disorders (ulcers, reflux) may benefit. The CBG is a plus for MS, Parkinson’s, ALS, etc. It should be non sedating at low to moderate doses and effective for breakthrough nerve pain and migraine headaches.